Join
Live feed
·
PRReleasevia Quantisnow
Akoya BioSciences Inc. logo

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

ByQuantisnow·Wall Street's wire, on your screen.
AKYA· Akoya BioSciences Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AKYA (Akoya BioSciences Inc.) and more on Quantisnow.